Your browser doesn't support javascript.
loading
TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies.
van der Ploeg, Kattria; Kirosingh, Adam S; Mori, Diego A M; Chakraborty, Saborni; Hu, Zicheng; Sievers, Benjamin L; Jacobson, Karen B; Bonilla, Hector; Parsonnet, Julie; Andrews, Jason R; Press, Kathleen D; Ty, Maureen C; Ruiz-Betancourt, Daniel R; de la Parte, Lauren; Tan, Gene S; Blish, Catherine A; Takahashi, Saki; Rodriguez-Barraquer, Isabel; Greenhouse, Bryan; Singh, Upinder; Wang, Taia T; Jagannathan, Prasanna.
Afiliación
  • van der Ploeg K; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Kirosingh AS; Department of Microbiology and Immunology, Stanford University, Stanford, CA 94305, USA.
  • Mori DAM; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Chakraborty S; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Hu Z; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA; Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, CA 94143, USA.
  • Sievers BL; J. Craig Venter Institute, La Jolla, CA 92037, USA.
  • Jacobson KB; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Bonilla H; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Parsonnet J; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Epidemiology and Population Health, Stanford University, Stanford, CA 94305, USA.
  • Andrews JR; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Press KD; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Ty MC; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Ruiz-Betancourt DR; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • de la Parte L; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Tan GS; J. Craig Venter Institute, La Jolla, CA 92037, USA; Division of Infectious Disease, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Blish CA; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.
  • Takahashi S; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  • Rodriguez-Barraquer I; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  • Greenhouse B; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  • Singh U; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Microbiology and Immunology, Stanford University, Stanford, CA 94305, USA.
  • Wang TT; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Microbiology and Immunology, Stanford University, Stanford, CA 94305, USA.
  • Jagannathan P; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Microbiology and Immunology, Stanford University, Stanford, CA 94305, USA. Electronic address: prasj@stanford.edu.
Cell Rep Med ; 3(6): 100640, 2022 06 21.
Article en En | MEDLINE | ID: mdl-35588734

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos